Our study demonstrates that triple-negative SCLC tumors (e.g., no expression of ASCL1, NEUROD1, and POU2F3) are heterogeneous and can be subclassified into SCLC-I and SCLC-M tumors. The gene discussed is NEUROD1; the disease is small cell lung carcinoma.